| PATENT ASSIGNEE'S COUNTRY | Germany |
| UPDATE | 04.00 |
| PATENT ASSIGNEE | This data is not available for free |
| PATENT CLAIMS |
Regime for the therapeutic management of benign prostatic hyperplasia in mammal without testosterone levels being in castration range, comprising - Adm LHRH antagonist CETRORELIX in regime wherein cetrorelix is adm at dosage of 0.5 mg/day over time & in amount sufficient to reduce vol of prostate & or BPH symp toms Without the side effects associated with testosterone levels being in a castration range |
| PATENT PHOTOCOPY | Available on request |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |